XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

ValueSets

28,934 resources

By Version

R2: 0
R2B: 0
R3: 1,154
R4: 23,630
R4B: 250
R5: 3,872
R6: 28

By Authority

none: 8,526
hl7: 17,851
ihe: 218
national: 1,280
who: 1,059

By Realm

none: 5,797
au: 87
be: 108
br: 73
ca: 242
ch: 395
cl: 150
cr: 11
cz: 46
de: 680
dk: 457
ee: 66
eu: 347
fi: 4
fr: 810
il: 144
in: 48
it: 92
jp: 71
nl: 950
no: 6
nz: 24
pt: 11
se: 10
tw: 159
uk: 23
us: 13,130
uv: 4,928
vn: 23
other: 5

Start Prev Rows 5400 - 5600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Source(s)
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.480	Cisplatin_Trodelvy	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.481	Cyclophosphamide	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.482	Methotrexate	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.483	Gemcitabine	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.484	Capecitabine	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.485	Eribulin	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.486	Doxorubicin	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.487	Vinorelbine	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.488	Epirubicin	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.489	Ixabepilone	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.490	Olaparib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.491	Talazoparib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.492	Entrectinib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.493	larotrectinib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.494	Alpelisib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.495	Capivasertib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.496	Pembrolizumab	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.497	Dostarlimab	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.498	Selpercatinib	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.499	Everolimus	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.500	Trastuzumab_deruxtecan	active	2024-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.501	Test 23	active	2024-09	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.502	All Metastatic sites Endometrial SNOMED	active	2024-09	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.503	All Metastatic sites Endometrial ICD9	active	2024-09	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.504	All Metastatic sites Endometrial ICD10	active	2024-09	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.505	All Metastatic sites Endometrial	active	2024-09	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.506	Create CRC_Cancer_T4a_Stage	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.507	Create CRC_Cancer_T4b_Stage	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.508	High Emetogenic Risk Chemotherapy	active	2025-04	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.510	InactiveFollowup	active	2025-05	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.53	MMR Gene Testing	active	2023-11	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.54	MSI High	active	2023-11	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.55	MSI High	active	2024-01	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.6	Orserdu	active	2023-08	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.61	Stage IIB or lower and limited	active	2023-11	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.62	Stage III or higher	active	2023-11	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.63	Stage III or higher	active	2023-11	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.64	Stage III or higher	active	2023-11	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.65	Staging Unknown	active	2023-11	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.66	Staging Unknown	active	2023-11	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.67	Staging Unknown	active	2023-11	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.68	Jemperli	active	2023-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.69	Uterine Sarcoma	active	2023-11	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.7	Her2 Test For Orserdu	active	2023-09	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.70	Tumor Histology	active	2023-11	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.71	Platinum based therapy	active	2023-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.72	Prior Therapies for Tucatinib	active	2023-12	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.73	Tucatinib	active	2023-12	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.74	Colorectal Cancer ICD10	active	2023-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.75	Colorectal Cancer ICD9	active	2023-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.76	Colorectal Cancer ICD9 and ICD10	active	2023-12	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.78	Advanced or Unresectable Colorectal Cancer Staging	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.79	0 to IIIB Colorectal Cancer Staging	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.80	Colorectal Cancer M1 Stage	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.81	RAS Genes	active	2023-12	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.82	RAS Gene Interpretation Negative LOINC	active	2023-12	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.83	RAS Gene Interpretation Negative SNOMED	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.84	RAS Gene Interpretation Negative NCM	active	2023-12	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.85	RAS Gene Negative	active	2023-12	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.86	RAS Gene Interpretation Positive SNOMED	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.87	RAS Gene Interpretation Positive LOINC	active	2023-12	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.88	RAS Gene Positive	active	2023-12	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.89	Her2 Testing	active	2023-12	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.90	Patient Reason	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.91	MSI High NCI	active	2024-01	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.92	MSI Low SNOMED	active	2024-01	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.93	MSI Low LOINC	active	2024-01	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.94	MSI Low NCI	active	2024-01	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.95	MSI Low	active	2024-01	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.96	MMR Deficient NCI	active	2024-01	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.97	MMR Proficient SNOMED	active	2024-01	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.98	MMR Proficient LOINC	active	2024-01	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1260.99	MMR Proficient NCI	active	2024-01	us	hl7	ncit
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1262.3	ICD9 Codes for HIV Diagnosis	active	2023-10	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.1	Inpatient Pneumonia Diagnosis	active	2023-12	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.11	Chest Imaging for Pneumonia, HCPCS	active	2023-11	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.12	Chest Imaging for Pneumonia Grouping Definition	active	2024-09	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.18	ICD9 Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.19	ICD10 Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.2	ICD9 Pneumonia Definition	active	2023-11	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.20	SNOMEDCT Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.21	Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.22	SNOMEDCT Pneumonia Definition	active	2023-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.23	CAP Concurrent Infections	active	2024-09	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.24	CAP Pneumonia Diagnostic	active	2024-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.25	Antibiotic Usage for CAP Diagnosis	active	2024-10	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.27	Legionella Presence by Urine Antigen or DNA	active	2024-09	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.29	Broad Spectrum Antibiotics for MDRO	active	2024-10	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.3	ICD10 Pneumonia Definition	active	2023-11	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.32	CPT Transplants, Stem Cell and Solid	active	2024-12	us	hl7	cpt
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.33	HCPCS Transplant, Stem Cell and Solid	active	2024-12	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.34	ICD10CM Transplant, Stem Cell and Solid	active	2024-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.35	ICD10PCS Transplant, Stem Cell and Solid	active	2024-12	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.37	SNOMEDCT Transplant, Stem Cell and Solid	active	2024-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.38	Transplant, Stem Cell and Solid	active	2024-12	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.39	Antibiotic Usage for CAP Duration	active	2024-12	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.40	CAP Sepsis Diagnostic	active	2024-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.41	CAP Respiratory Failure Diagnostic	active	2024-12	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.42	MRSA Organism or Substance in Lab Results	active	2024-12	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.8	Systemic Antimicrobials	active	2023-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1264.9	Chest Imaging for Pneumonia, CPT	active	2023-11	us	hl7	cpt
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.1	Problem Type	active	2025-04	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.10	Information Source for Medication Adherence HSLOC	active	2024-03	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.11	Information Source for Medication Adherence	active	2024-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.14	Unknown and Asked but Unknown (DAR)	active	2024-10	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.15	Yes or No SCT	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.16	Answer Set with Yes No and Unknowns	active	2024-10	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.17	Common LOINC Lab Codes	active	2024-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.18	Radiology Procedures (LOINC)	active	2024-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.21	Universal Common LOINC Lab Orders	active	2024-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.22	Route of Administration of Therapeutic Agents	active	2024-10	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.23	Encounter Type	active	2025-05	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.27	Social History Type (LOINC)	active	2025-05	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.28	Social History Type	active	2025-04	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.3	Smoking status comprehensive	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.4	Smoking Status Type LOINC	active	2024-02	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.5	Smoking Status Pack Years SCT	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.6	Smoking Status Type	active	2024-02	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.7	Information Source for Medication Adherence HL7 Role Code	active	2024-03	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.8	Information Source for Medication Adherence ParticpationFunction	active	2024-03	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1267.9	Information Source for Medication Adherence SCT	active	2024-03	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.1	Malnutrition	active	2024-10	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.10	Fracture	active	2025-03	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.11	Transplant Diagnoses	active	2025-04	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.13	Transplant Diagnoses ICD10CM	active	2025-04	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.14	Transplant Diagnoses SNOMED CT	active	2025-04	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.15	Respiratory Procedures	active	2025-04	us	hl7	cpt
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.3	Diabetes	active	2025-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.4	Diabetes	active	2025-03	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.5	Diabetes	active	2025-03	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.6	Immobility	active	2025-03	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.7	Smoking status	active	2025-03	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.8	Obesity	active	2025-03	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1272.9	Hormone Therapy	active	2025-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1282.1	Drug Intervention Not Indicated/Contraindicated	active	2024-11	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1282.10	Endotracheal Intubation	active	2025-02	us	hl7	cpt
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1282.2	Procedure Not Indicated/Contraindicated	active	2024-11	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1282.9	Mechanical Circulatory Assist Device	active	2025-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1289.1	RXNormSBD0305	active	2025-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1289.2	RXNormSCD0305	active	2025-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113762.1.4.1290.4	Sequential Organ Failure Assessment SOFA	active	2025-04	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.1.11.10612	Unknown Null	active	2019-03	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.1.11.19601	x_ServiceEventPerformer	active	2024-06	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.1.11.20549	Criticality Observation	active	2024-06	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.10.20.15.2.5.1	Initial Case Report Trigger Code Result Status	active	2024-08	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.10.20.15.2.5.12	Therapeutic Response to Medication	active	2024-08	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.1.5.9.2	Codes for MDRO and CDI Summary Data LTCF	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.1.5.9.3	NHSNPrimaryResidentServiceType	active	2020-06	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.1.5.9.4	Codes for Denominators for Long Term Care Locations LTCF	active	2023-02	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.1.5.9.5	Codes for Prevention Process Measures LTCF	active	2023-02	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.1.9.1	NHSNReportNoEventsMDROLTCF	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.10	Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Data	active	2019-08	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.11	Codes for Hemovigilance (HV) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.12	Codes for Intensive Care Unit (ICU) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.13	Codes for Neonatal Intensive Care Unit (NICU) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.15	Codes for Prevention Process and Outcome Measures (POM) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.16	Codes for Specialty Care Area (SCA) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.17	Codes for Vascular Access Type (Dialysis) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.18	NHSNReportNoEventsICU	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.19	NHSNReportNoEventsNICU	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.20	NHSNReportNoEventsSCA	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.21	NHSNReportNoEventsMDRO	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.22	NHSNReportNoEventsDialysis	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.24	NHSNVascularSpecimenCollectionSite	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.29	NHSNSSIDetectionMethod	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.3	NHSNLastLocationEncounterTypeCode	active	2020-06	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.30	NHSNLOS/MENDischargeDisposition	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.31	NHSNSSIDetectionMethodType	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.32	Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.33	NHSNReportNoEventsOPCSameDayOutcomeMeasures	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.34	NHSNOPCProcedureCategoryCode	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.35	NHSNReportNoEventsAR	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.4	NHSNDrugSusceptibilityTestMethod	active	2020-04	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.40	NHSN COVID19 Case Classification	active	2021-04	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.5	NHSN Pathogen Reduced Apheresis Platelet Usage	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.50	NHSNGenotypicTestInterpretation	active	2024-08	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.6	HealthcarePersonnelType	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.7	NHSNInfluenzaVaccinationSetting	active	2022-03	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.8	Codes for Antimicrobial Resistance Option (ARO) Summary Data	active	2020-11	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.10.20.5.9.9	Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Data	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.11.20.12.1	Personal And Legal Relationship Role Type	active	2024-06	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.21	AgePQ_UCUM	active	2024-06	us	hl7	ucum
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.32	DIRDocumentTypeCodes	active	2024-06	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.47	ADL Result Type	active	2024-06	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.49	Residence and Accommodation Type	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.50	Sensory Status Problem Type	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.51	Healthcare Agent Qualifier	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.52	Encounter SCT	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.56	Referral Types	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.62	Related Document (append/replace)	active	2024-06	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.66	Patient Referral Act moodCode	active	2024-06	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.68	Note Types	active	2024-06	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.11.20.9.69.4	Advance Healthcare Directive Categories LOINC	active	2025-04	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.13.1	NHSNEncounterTypeCode	active	2019-08	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.13.10	NHSNASAClassCode	active	2019-08	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.13.11	NHSNSpinalFusionLevelCode	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.13.12	NHSNOccasionOfDetectionCode	active	2020-08	us	hl7	cdc
us.nlm.vsac	R4	2.16.840.1.113883.13.13	NHSNDrugSusceptibilityFindingCode	active	2020-04	us	hl7	tho
us.nlm.vsac	R4	2.16.840.1.113883.13.15	NHSNDrugSusceptibilityTestsCode	active	2025-02	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.13.16	NHSNPathogenCode	active	2023-11	us	hl7	sct